Brixadi (buprenorphine-XR) for the Treatment of Opioid Use Disorder

Sponsor: The American osteopathic Academy of Addiction Medicine

During this lecture participants will learn how to treat patients with opioid use disorder using the newly FDA-approved injectable formulation of buprenorphine, Brixadi.

At the conclusion of this seminar, participants will be able to:

1. Discuss how to start patients with OUD on Brixadi
2. Adjust the dose to alleviate opioid withdrawal, suppress cravings and use of opioids
3. Name typical adverse effects of the medication
4. Describe how the medication is to be administered and possible sites for injection

For more information and to register click here

Event Details